A purple and pink letter v on a white background.
January 2, 2020

Venus Versa™ featured in Dermatology Times

Venus Versa™ was recently featured in a Dermatology Times article alongside our customer, and respected key opinion leader, Dr. Michael Gold. The article is based on a talk given at the Cosmetic Surgery Forum 2019 in Nashville Tennessee where he listed Venus Versa™ as one of the devices that he uses to get the “most successful outcomes for his patients”. 

Venus Versa™, as explained by Dr. Michael Gold “is a multi-treatment system”. He highlighted the many treatments that the system’s IPL (Intense Pulsed Light) applicators can offer, stating that they “can be used as a photofacial machine , for hair removal or as a dual-light acne treatment .”

Dr. Gold also noted that when used in conjunction with the Multi-Polar RF and Pulsed Electro Magnetic Fields (PEMF) applicators, these treatments can bring “results [that] are pretty spectacular”. He stated that, “if you do a series of three of these treatments, we’re finding incredible results in wrinkles, texture, tones, tightening, improvement and acne scars or other kinds of imperfections in the skin.” 

Venus Versa™ is a versatile, multi-application platform that provides some of the most popular, non-invasive aesthetic treatments. It is equipped with three different technologies that come together in our comprehensive protocol - TriBella™ total facial therapy . The three modalities used for a TriBella™ treatment include photorejuvenation, NanoFractional Radio Frequency for skin resurfacing , and Venus Concept’s proprietary (MP) 2 technology (a combination of Multi-Polar Radio Frequency and Pulsed Electro Magnetic Fields)

Interested in reading the full article from Dermatology Times? Read it here: Combining Energy Treatments for Optimal Outcomes

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.